PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.

Clinical trial NCT02362620 · UNKNOWN

Trial details

NCT number: NCT02362620
Sponsor: Centro Nacional de Investigaciones Oncologicas CARLOS III
Status: UNKNOWN
Study type: OBSERVATIONAL

Advanced Prostate Cancer Cabazitaxel Docetaxel

Start date: 2014-05-01
Primary completion: 2018-04-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.